 | |
- close
- close
|
UnBiasedTrading (TM)
4 hrs ago
Comment
Most swing traders are sidelined by the choppy range-bound trade in the SPX and other equities markets right now. While banks, GS and other financials remain in the saggy category (possible 4th wave for GS not complete), leading equity indices...
UnBiasedTrading (TM)
Nov 28
Comment
We'll have an interesting weekend including taking a look at what some others are seeing and saying on the markets. Recently there have been a number of views and items pointed out, such as mutual funds' low amounts of cash (bearish), investors...
Charts and Coffee Blog
Nov 16
Comment
Today is repeat of last Monday. Look familiar? TRIN has been under .5 most of the day. Will it sink even lower into the close? My only short is PZZA so I am pleased with today’s action. This rally has bailed me out of my NLST short. [...]
FierceBiotech
Nov 11
Comment
TRIN Pharma GmbH has appointed Stefan Wohlfeil as to be the company's new CEO. Release
RXi Pharmaceuticals has announced that Noah D. Beerman has joined the company as its new President and CEO. Release
Amarin Corporation has announced the...
Charts and Coffee Blog
Nov 10
Comment
So far, the bears have successfully defended their territory this morning. The bulls briefly pushed the ES over its overnight high but the breakout has failed. The prior intraday high on the QQQQs was $43.73. The QQQQs pushed up to $43.77 but...
Marketwire
Sep 28
Comment
LONDON -- (Marketwire) -- 09/28/09 -- Thomson Reuters today announced that it has integrated Kamakura's default probability service into its flagship financial desktop, Reuters 3000Xtra. Kamakura's default probabilities are now available via Reuters
Marketwire
Sep 3
Comment
NEW YORK, NY -- (Marketwire) -- 09/03/09 -- Thomson Reuters and BioCentury are pleased to announce the presenting companies in their 16th Annual NewsMakers in the Biotech Industry conference. The conference takes place on September 16th at New York
MarketWatch
Aug 7
Comment
Thomson Reuters Corp. said Friday that shareholders voted to unify the company's dual-listed structure. If Thomson Reuters gets court approval, the last day of shares trading on the London Stock Exchange and American depositary shares on the...
MarketWatch
Aug 6
Comment
Thomson Reuters Corp. said Thursday that second-quarter earnings rose to $325 million, or 38 cents a share, from $154 million, or 19 cents a share, in the year-earlier period. On an adjusted basis, earnings in the latest period were 58 cents a...
MarketWatch
Jun 23
Comment
Gains from media giant Thomson Reuters and drugmakers help London shares to modest advances.
|
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
|
||
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
TRIN AT A GLANCE
References
| ||||||
|
|
